ACE2 and gout: Probenecid, a drug for treating gout, was found to decrease ACE2 expression in a renal cortical cell line (logFC = −0.61, adjusted P = 0.001, Fig 22D); this drug has been proposed to be repurposed for anti‐influenza therapy (Perwitasari et al, 2013).